儿童青光眼药物治疗的研究进展  

Research advances of medical therapy for pediatric glaucoma

作　　者：朱彦霏 才瑜[1] Zhu Yan-fei;Cai Yu(Department of Ophthalmology,PeKing University First Hospital,Key Laboratory of Vision Loss and Restoration,Ministry of Education,Beijing 100034,China)

机构地区：[1]北京大学第一医院眼科,100034

出　　处：《中国斜视与小儿眼科杂志》2022年第1期45-47,共3页Chinese Journal of Strabismus & Pediatric Ophthalmology

摘　　要：尽管手术是儿童青光眼的主要治疗措施,药物治疗仍占据重要地位,其作用根据儿童青光眼类型及各自特征有很大差异。儿童对药物治疗的反应在很多方面也与成人不同,目前几乎所有药物都缺少针对儿童的安全性和有效性的临床研究。儿童用药依从性问题、药物在不同国家的价格和获得渠道,也会影响有效的长期药物治疗。本文就儿童青光眼常用药物在临床中的有效性和安全性以及实际应用中面临的障碍作一综述。Although surgery is the main treatment for pediatric glaucoma,medical therapies may also play an important role,and the effects varies greatly according to the types and characteristics of pediatric glaucoma.Children also differ in many ways from adults in how they respond to medication,and there is currently a lack of safety and efficacy of clinical trails for nearly all drugs in children.Medication compliance and the price and access of drugs in different areas can also influence log-term medication application.This article reviews the clinical efficacy and safety of commonly used drugs for pediatric glaucoma and the obstacles in their application.

关 键 词：儿童青光眼 药物治疗 综述 

分 类 号：R775[医药卫生—眼科]